Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Primerdesign partners with Origin Sciences to create novel rectal mucosal extraction workflow

25

Mar 2026

Primerdesign partners with Origin Sciences to create novel rectal mucosal extraction workflow

Primerdesign (part of the Novacyt Group), a company focused on the design, manufacture, validation and supply of nucleic acid extraction and real-time PCR kits, and Origin Sciences (Origin), a company pioneering the detection and diagnosis of gastrointestinal (GI) disease through an unprecedented focus on a unique biospecimen: rectal mucus; today announced a strategic partnership to create a new protocol that optimizes DNA extraction from novel rectal mucosal samples.

Navigating the moral landscape of pediatric AI surgery

25

Mar 2026

Navigating the moral landscape of pediatric AI surgery

Technological innovation has always driven surgical progress, and AI now represents the next transformative wave. Machine learning models are now being developed to predict surgical risks, assist in diagnosing rare congenital disorders, analyze imaging data, and anticipate postoperative complications. Risk prediction tools have already shifted from traditional statistical methods to more complex machine learning approaches, improving their ability to account for nonlinear interactions.

Pediatric mental health triage often inaccurate in emergency departments

24

Mar 2026

Pediatric mental health triage often inaccurate in emergency departments

In emergency medicine, triage differentiates patients who require immediate attention from those who can safely wait for care. When it comes to children's mental or behavioral health, however, triage scores were found to be inaccurate in two-thirds of the cases when compared to the level of care the child actually received during their emergency visit, according to a new study published in JAMA Network Open.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.